Biology subjects

Lismont, S.

Publications and source records attributed to Lismont, S..

3 recordsLinked to original sources

bioRxiv2023

APP substrate ectodomain defines A beta length by restraining gamma-secretase processivity and facilitating product release

Sequential proteolysis of the amyloid precursor protein (APP) by {gamma}-secretases (GSECs) generates amyloid-{beta} (A{beta}) and defines the proportion of short-to-long A{beta} peptides, which is tightly connected to Alzheimers disease (AD) pathogenesis. Here, we study the mechanism controlling substrate processing by GSECs and defining product length. We found that polar interactions established by the APPC99 ectodomain (ECD), involving but not limited to its juxtamembrane region, restrain both the extent and degree of GSEC processive cleavage by destabilizing enzyme-substrate (E-S) interactions. We show that increasing hydrophobicity at APPC99-ECD - due to mutation or ligand binding - attenuates this substrate-driven product release mechanism, and rescues the effects that AD pathogenic variants exert on A{beta} profiles. In addition, our study reveals that APPC99-ECD facilitates the paradoxical production of longer A{beta}s caused by some GSEC inhibitors that act as high-affinity competitors to the substrate. These findings assign a pivotal role to the substrate ECD in the sequential proteolysis by GSEC and suggest it as a sweet spot for the potential design of APP targeting compounds selectively promoting its processing by GSEC.

biochemistry↗

bioRxiv2023

Structure of γ-secretase (PSEN1/APH-1B) in complex with Aβ46 provides insights into amyloid-β processing and modulation by the APH-1B isoform

Deposition of amyloid-{beta} (A{beta}) peptides in the brain is a hallmark of Alzheimers disease. A{beta}s are generated through sequential proteolysis of the amyloid precursor protein by the {gamma}-secretase complexes (GSECs). A{beta} peptide length, which is modulated by the Presenilin (PSEN) and APH-1 subunits of GSEC, is critical for Alzheimers pathogenesis. Despite high relevance, mechanistic understanding of the proteolysis of A{beta}, and its modulation by APH-1, remain incomplete. Here, we report cryo-EM structures of human GSEC (PSEN1/APH-1B) reconstituted into lipid nanodiscs in apo form and in complex with the intermediate A{beta}46 substrate. We found a divergent APH-1 loop to be involved with PSEN1 in substrate-binding-induced concerted rearrangements. Upstream the catalytic site, A{beta}46 structure is similar to the endopeptidase substrates and is stabilised by polar interactions including a previously unseen interaction with PSEN1 loop1. The hybrid {beta}-sheet was not observed downstream the catalytic site.

molecular biology↗

bioRxiv2023

Alzheimer's disease linked Aβ42 exerts product feedback inhibition on γsecretase impairing downstream cell signaling

Amyloid {beta} (A{beta}) peptides accumulating in the brain are proposed to trigger Alzheimers disease (AD). However, molecular cascades underlying their toxicity are poorly defined. Here, we explored a novel hypothesis for A{beta}42 toxicity that arises from its proven affinity for {gamma}-secretases. We hypothesized that the reported increases in A{beta}42, particularly in the endolysosomal compartment, promote the establishment of a product feedback inhibitory mechanism on {gamma}-secretases, and thereby impair downstream signaling events. We show that human A{beta}42 peptides, but neither murine A{beta}42 nor human A{beta}17-42 (p3), inhibit {gamma}-secretases and trigger accumulation of unprocessed substrates in neurons, including C-terminal fragments (CTFs) of APP, p75 and pan-cadherin. Moreover, A{beta}42 treatment dysregulated cellular homeostasis, as shown by the induction of p75-dependent neuronal death in two distinct cellular systems. Our findings raise the possibility that pathological elevations in A{beta}42 contribute to cellular toxicity via the {gamma}-secretase inhibition, and provide a novel conceptual framework to address A{beta} toxicity in the context of {gamma}-secretase-dependent homeostatic signaling.

biochemistry↗